Real-world study of the multimorbidity and health service utilisation among individuals with non-diabetic hyperglycemia and type 2 diabetes mellitus in North West London
Both NDH and T2DM were associated with significant multimorbidity alongside primary and secondary care utilisation. Given the morbidity highlighted with NDH, we highlight the need for earlier detection of NDH, recognition of multimorbidity associated with both NDH and T2DM, as well as the need for the further implementation of interventions to prevent progression to T2DM/multimorbidity.
Authors
- Rakesh Dattani (ORCID: https://orcid.org/0000-0002-1257-1017)
- Tony Willis
- Benjamin F. Pierce (ORCID: https://orcid.org/0000-0002-0834-5201)
- Zia Ul Haq (ORCID: https://orcid.org/0000-0001-5124-2171)
- Frederick W.K. Tam (ORCID: https://orcid.org/0000-0002-0614-9856)
- Amanda Lucas (ORCID: https://orcid.org/0000-0003-3262-7820)
- Moulesh Shah (ORCID: https://orcid.org/0009-0006-5527-9549)
- Tahereh Kamalati (ORCID: https://orcid.org/0009-0007-7410-6552)
- Ahmed Baruwa
- Thomas Griffiths (ORCID: https://orcid.org/0000-0002-1240-2547)
- Jack Chilcott
- Livi Bickford-Smith
- Andrew Frankel
Institutions
- AstraZeneca (United Kingdom) (GB)
- Imperial College Healthcare NHS Trust (GB)
- Kings Health Partners (GB)
- Imperial College London (GB)
Publication Details
- Journal
- BMJ Open Diabetes Research & Care
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/bmjdrc-2023-003873
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- AstraZeneca
- Imperial College London